KIF18B:在信号通路中发挥重要作用,在瘤发育中成为潜在的耐药标
Shicheng Chen1, Bo Yu1, Guo Tu DU2
1Department of Urology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, P. R. China.
Discover oncology
|September 11, 2024
概括
基尼辛家族成员KIF18B促进瘤生长和抵抗癌症治疗. 准KIF18B为开发新的抗癌药物和克服恶性瘤治疗阻力提供了一个有前途的战略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 基因素-8家族成员KIF18B调节微管体动力学,螺旋组合和染色体对齐.
- KIF18B的失调与各种细胞过程和癌症的发展有关.
研究的目的:
- 审查KIF18B在恶性瘤中的结构,生理功能和作用.
- 探索KIF18B与关键致癌信号通路之间的关联.
- 评估KIF18B作为癌症治疗的潜在治疗标.
主要方法:
- 关于KIF18B结构,功能和与癌症有关的途径的文献综述.
- 对将KIF18B表达与瘤恶性病变和耐治疗性相关的研究进行分析.
- 在KIF18B的背景下检查信号通路,包括PI3K/AKT,Wnt/β-catenin和mTOR.
主要成果:
- KIF18B在微管动力学和染色体分离中起着至关重要的作用.
- KIF18B的升高与瘤恶性病变的增加以及对放射治疗和化疗的耐药性有关.
- KIF18B与PI3K/AKT,Wnt/β-catenin和mTOR等信号通路相互作用,有助于瘤发生.
结论:
- KIF18B是促进癌症进展和治疗耐药性的重要因素.
- 向KIF18B为治疗恶性瘤提供了一个新的治疗策略.
- 对KIF18B抑制的进一步研究可能会导致更有效的抗癌药物和克服化疗耐药性.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K


